Robert is originally from Palo Alto and moved to London with his family as a child and has resided permanently in the UK since the 1980s. He has more than 30 years of experience in the natural products industry in the United States, Europe and China. His interest in medicinal plants came about through his personal experience of having been successfully treated for a debilitating chronic disease with traditional Chinese medicine. After this experience he changed careers and became one of the pioneering entrepreneurs in plant-derived healthcare products. Robert has a particular interest in China where he has spent more than 25 years developing commercial and academic collaborations. In December 2013 he was a member of the British business delegation that accompanied David Cameron on his first Trade Mission to China.
Chief Financial Officer
Keith qualified as a Chartered Accountant with KPMG. He was COO and CFO at Phytopharm plc where he successfully re-structured the business and enabled the company to close a £25 million fundraising. He has helped guide a number of international healthcare businesses including: On Medica an international E-detailing business, Verigen, a German based multinational tissue engineering business, and Vision RT, a business utilising 3D surface imaging technology to improve the efficacy of radiotherapy treatment.
Wouter Claerhout LLM MA
Chief Marketing Officer
Wouter brings 20+ years of B2B experience in sales, marketing, commercial management, strategic supply contracts, innovation management and communication. Before joining Phynova, Wouter was head of global marketing – Human Nutrition and Health (HNH) at Royal DSM, a global science-based company active in health, nutrition and materials. The role included ownership of the HNH innovation pipeline. From 2010 until 2014, Wouter was based in Singapore as DSM’s Marketing Director HNH APAC. Partnering with customers to make their brands succeed was Wouter’s pride and joy. From 1995 to 2010, Wouter held roles in commercial management, project management and sales in Belgium, The Netherlands and Switzerland. Wouter has academic qualifications in Law, Marketing and Business Administration.
Andrew Gallagher MSc MBA
Chief Operating Officer
Andrew has been developing healthcare products (Rx, OTC and consumer healthcare) from plants for a number of years. He has broad operational experience across the development value chain, from product discovery to clinical development and commercialisation. He previously worked as biochemistry lecturer at the University of Natal (South Africa) and in business development for the clinical research organisation Kendle (acquired by INC Research). Andrew holds an MSc (Biology) from the University of Natal and an MBA (Finance) with Distinction from the University of Leicester.
Hongwen Yu MSc
Executive Vice President
Hongwen was a lecturer in the Department of Pharmacy, Shanghai University. She has gained extensive experience with plant-based medicines from “field to final dosage form”. She has prepared initial Chemistry, Manufacturing and Control (CMC) documents for submission to ethics committees and regulatory bodies for clinical trial approval and has successfully managed several development programmes from concept to products in clinical phase. As a pharmacognosist, she is experienced in the authentication and quality assessment of natural products.
Xiaofei Gao MSc
Regulatory Affairs Manager
Xiaofei, or Fei for short, manages in-house regulatory affairs for Phynova, specialising in the registration of traditional Chinese medicines as OTC drugs in Europe. She comes from a background of University based systematic reviews, where she worked for the University of Leeds and University of Warwick as a systematic reviewer for evidence synthesis projects. Prior to this she worked as a pharmaceutical sales rep, where she was awarded ‘top salesperson’ of Tanabe China. Fei holds an MSc in Health Technology Assessment from the University of Birmingham and a BSc Pharmacy from Jinan University in China.
Alice Lyon Dip. Phyt. MNIMH RCHM
Alice is a qualified medical herbalist in both Western and traditional Chinese herbal medicine. She is a member of the National Institute of Medical Herbalists (NIMH) and the Register of Chinese Herbal Medicine (RCHM). As well as training in the UK at the School of Phytotherapy she was one the first western students to study at the College of Traditional Chinese Medicine in Guangzhou, China. For several years she held practices in London and Oxford and managed the East West Herb Shop and Clinic in Neal’s Yard, Covent Garden. She also worked as a senior consultant herbalist at Sen Health Care in London. She co-authored ‘’The Chinese Herbal Cookbook, Healing Foods from East and West’’.
Consumer Healthcare Division, China:
Zhong Zhong BSc
Chief Executive Officer (Beijing)
Zhong Zhong co-founded Phynova’s Chinese subsidiary, BCCL. His career has been spent in botanical product industries. His previous appointments include MD of Hunan Hill Natural Pharmaceutical Ltd., Head of TCM Department in Beijing Union Bio-Technique Institute, Deputy General Manager of the National Centre for Reference Compounds Research, and Manager of IMPLAD’s Development Company. He has broad experience in product development, manufacturing, international trade, marketing and regulations for botanical products.
Chen Xie PhD
Chief Science Officer (Beijing)
Chen is the co-founder of Phynova’s Chinese subsidiary, BCCL and has over 18 years’ experience in botanic drug and product development. She holds her MSc degree from Peking Union Medical University and her PhD in plant chemistry and bioactivities from King’s College, University of London. Prior to Botanic Century, she worked for IMPLAD, Chinese Academy of Medical Sciences serving as Professor and Head of the Phytochemistry Department. She has successfully led several new drug development programs and has extensive experience in Chinese regulatory affairs.